WeVote

Bill

Bill

SB 503

Pharmacy benefit administration.

2025 Regular Session Introduced by Mike Bohacek and 5 co-sponsors

SB 503 regulates Indiana pharmacy benefit managers' administration practices, advancing through committee toward appropriations review to address drug pricing and access issues.

Committee report: amend do pass adopted; reassigned to Committee on Appropriations
0
WeVote Research Nonpartisan
Bill Summary · SB 503

Legislative bill overview

SB 503 addresses the regulation and administration of pharmacy benefit managers (PBMs) in Indiana. The bill has advanced through committee with an amendment and is currently under appropriations review. While specific provisions aren't detailed in the available information, Indiana bills on this topic typically regulate PBM practices, transparency requirements, or reimbursement rates.

Why is this important

PBMs control drug pricing and access for millions of Hoosiers, making regulations directly affect medication affordability and pharmacy operations. Recent national scrutiny of PBM practices has prompted multiple states to implement oversight measures, and Indiana's approach could model similar reforms.

Potential points of contention

  • Pharmacy reimbursement rates: Proposals to regulate how PBMs pay pharmacies versus what they charge patients often face PBM industry opposition
  • Transparency requirements: Mandating disclosure of PBM pricing algorithms and negotiation practices may burden administrative costs while improving market clarity
  • Economic impact: Restrictions on PBM operations could increase insurance premiums or reduce services unless offset by efficiency gains

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.